This inventor holds 1 USPTO granted patent. Top assignee: Genentech, Inc.. Active years: 2000.
Company Filing History:
Years Active: 2000
Title: Iain C Robinson: Innovator in Insulin-like Growth Factor Agonist Molecules
Introduction
Iain C Robinson is a notable inventor based in St. Albans, GB. He has made significant contributions to the field of biochemistry, particularly in the development of insulin-like growth factor (IGF) agonist molecules. His work has implications for enhancing serum and tissue levels of active IGFs in mammals.
Latest Patents
Robinson holds a patent for compounds that prevent the interaction of an IGF with any of its binding proteins, while not affecting a human IGF receptor. This innovative approach has the potential to advance therapeutic strategies in various medical applications. He has 1 patent to his name, showcasing his expertise in this specialized area.
Career Highlights
Iain C Robinson is associated with Genentech, Inc., a leading biotechnology company known for its focus on innovative medicines. His role at Genentech has allowed him to contribute to groundbreaking research and development in the field of growth factors.
Collaborations
Throughout his career, Robinson has collaborated with esteemed colleagues, including Ross G Clark and Henry Bernard Lowman. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Iain C Robinson's work in insulin-like growth factor agonist molecules exemplifies the impact of innovative research in biotechnology. His contributions continue to influence the field and pave the way for future advancements.